Skip to content

Role of Endothelial Function, Muscular Fitness and Metabolism in Functional Activity in Patients With Chronic Heart Failure (CHF)

Role of Endothelial Function, Muscular Fitness and Metabolism in Functional Activity in Patients With Chronic Heart Failure

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01139086
Enrollment
100
Registered
2010-06-08
Start date
2010-05-31
Completion date
2011-05-31
Last updated
2010-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure, Coronary Disease, Dilated Cardiomyopathy

Keywords

chronic heart failure, isokinetic test, near-infrared spectroscopy, laser Doppler flowmetry, endothelial function

Brief summary

Shortness of breath, fatigue, and exercise intolerance are clinical symptoms of chronic heart failure (CHF). Recent studies suggested that peripheral impairment was the major cause of clinical symptoms, and mechanism may be related to neuroendocrine impairment and vascular smooth muscle dysfunction. It results in increased peripheral resistance that may influence limb blood flow, muscle fitness and activities of daily.The purposes of this study are 1. to compare muscular strength, endurance, and perfusion of quadriceps between CHF patients and healthy controls by isokinetic test and near-infrared spectroscopy (NIRS) and difference in activities of daily living 2. to compare endothelium function between CHF patients and healthy control subjects 3. the relationship between endothelium function, muscular strength, endurance, perfusion, and metabolism of quadriceps.

Interventions

None listed

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
40 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 40-75 years * Chronic heart failure: ejection fraction\<40% and at stable condition * Coronary Disease and dilated cardiomyopathy without heart failure * Control group without diagnosis of any heart disease

Exclusion criteria

* Clinical diagnosis of neuromusculoskeletal , pulmonary, or other systemic diseases that may affect the testing of the study

Design outcomes

Primary

MeasureTime frameDescription
muscle strength and endurancebaselineMeasured by biodex

Secondary

MeasureTime frameDescription
Walking distance in 6-minute walking testbaselinewalking distance (m)
laser Doppler flowmetry combine iontophoresisbaselineTo measure the blood flux (PU) response to Ach (endothelial-dependent agent) and SNP (endothelial-independent agent)
skeletal muscle oxygenation responsebaselineMeasured by near-infrared spectroscopy
questionnaire (functional activity and quality of life)baseline
Analysis of venous blood samplebaselineBy standard venipuncture
sit-to-stand testbaselineMeasured times in 1 minute

Countries

Taiwan

Contacts

Primary ContactYing-Tai Wu, Ph.D
ytw@ntu.edu.tw+886-2-33668129

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026